chr5-80655040-G-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002439.5(MSH3):c.237+76G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.141 in 867,144 control chromosomes in the GnomAD database, including 10,729 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.12 ( 1211 hom., cov: 30)
Exomes 𝑓: 0.15 ( 9518 hom. )
Consequence
MSH3
NM_002439.5 intron
NM_002439.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0510
Genes affected
MSH3 (HGNC:7326): (mutS homolog 3) The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011]
DHFR (HGNC:2861): (dihydrofolate reductase) Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. While the functional dihydrofolate reductase gene has been mapped to chromosome 5, multiple intronless processed pseudogenes or dihydrofolate reductase-like genes have been identified on separate chromosomes. Dihydrofolate reductase deficiency has been linked to megaloblastic anemia. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 5-80655040-G-T is Benign according to our data. Variant chr5-80655040-G-T is described in ClinVar as [Benign]. Clinvar id is 1261132.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081.7 | c.237+76G>T | intron_variant | Intron 1 of 23 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
MSH3 | ENST00000667069.1 | c.237+76G>T | intron_variant | Intron 1 of 21 | ENSP00000499502.1 | |||||
MSH3 | ENST00000670357.1 | n.237+76G>T | intron_variant | Intron 1 of 24 | ENSP00000499791.1 | |||||
DHFR | ENST00000439211.7 | c.-551C>A | upstream_gene_variant | 1 | NM_000791.4 | ENSP00000396308.2 | ||||
MSH3 | ENST00000658259.1 | c.-154G>T | upstream_gene_variant | ENSP00000499617.1 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 17873AN: 151624Hom.: 1211 Cov.: 30
GnomAD3 genomes
AF:
AC:
17873
AN:
151624
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.146 AC: 104802AN: 715412Hom.: 9518 Cov.: 10 AF XY: 0.149 AC XY: 53990AN XY: 362548
GnomAD4 exome
AF:
AC:
104802
AN:
715412
Hom.:
Cov.:
10
AF XY:
AC XY:
53990
AN XY:
362548
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.118 AC: 17865AN: 151732Hom.: 1211 Cov.: 30 AF XY: 0.116 AC XY: 8584AN XY: 74154
GnomAD4 genome
AF:
AC:
17865
AN:
151732
Hom.:
Cov.:
30
AF XY:
AC XY:
8584
AN XY:
74154
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 22, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at